Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZETA vs MRNA✓SelectedUSD · MRNAZETA vs MRNA performance historyLatest closeAs of+1.25%11/18
Stock and ETF performance explorer

ZETA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+295.8%
MRNA return
+156.2%
Excess return
+139.6%
Maximum drawdown
-70.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.3%-4.8%+6.1%+1.5%
7D-10.0%-20.9%+10.9%-9.0%
30D+4.5%-13.3%+17.8%+5.1%
3M+20.3%+212.6%-192.3%+9.3%
6M+77.0%+309.0%-232.1%+54.1%
YTD+66.9%+567.3%-500.4%+35.2%
1Y+95.8%+689.7%-593.8%+54.5%
All+295.8%+156.2%+139.6%+212.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling